home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Suppression Of Colorectal Cancer Progression

  June, 28 2005 8:47
your information resource in human molecular genetics
The expression of an intestinal epithelial cell receptor is silenced in most human colorectal cancers that progress from benign to malignant, according to a Biology Letter in the 23 June 2005 issue of Nature (Vol. 435, No. 7045, pp. 1126-1130). In addition, Hans Clevers and colleagues report that loss of expression of this receptor, EphB2, accelerates the progression of colorectal cancer in mice.

This study contradicts previous work suggesting that EphB2 would be a good target in cancer therapy because of its overall upregulation in colorectal cancers compared with normal intestinal tissue. The authors note that this discrepancy underscores the need for careful study of potential drug targets.


Hans Clevers (Hubrecht Laboratory, Utrecht, The Netherlands)
E-mail: clevers@niob.knaw.nl

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.